Davide Soldato
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Risks and Factors
- Cancer survivorship and care
- PARP inhibition in cancer therapy
- COVID-19 and healthcare impacts
Papers in
- Oncology 20
- Cancer Risks and Factors 5
- Cancer survivorship and care 5
- Cancer Immunotherapy and Biomarkers 4
- Global Cancer Incidence and Screening 3
-
- Prostate Cancer Treatment and Research 3
- Co-authors
- Antonio Di Meglio (13 shared papers)Matteo Lambertini (10 shared papers)Daniele Presti (7 shared papers)Francesco Boccardo (3 shared papers)Carlo Messina (2 shared papers)Elisa Zanardi (3 shared papers)Elena Castro (2 shared papers)Carlo Cattrini (3 shared papers)
In The Last Decade
Davide Soldato
26 papers receiving 314 citations
Peers
Comparison fields: 5 of 53
- Oncology 166
- Cancer Research 42
- Pulmonary and Respiratory Medicine 77
- Reproductive Medicine 13
- Health Informatics 2
Countries citing papers authored by Davide Soldato
This map shows the geographic impact of Davide Soldato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Soldato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Soldato more than expected).
Fields of papers citing papers by Davide Soldato
This network shows the impact of papers produced by Davide Soldato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Soldato. The network helps show where Davide Soldato may publish in the future.
Co-authors
The 25 scholars most cited alongside Davide Soldato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 82 | |
| 2 | 2022 | 50 | |
| 3 | 2020 | 39 | |
| 4 | 2020 | 23 | |
| 5 | 2023 | 18 | |
| 6 | 2023 | 17 | |
| 7 | 2024 | 16 | |
| 8 | 2020 | 15 | |
| 9 | 2020 | 14 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 6 | |
| 12 | 2017 | 6 | |
| 13 | 2019 | 3 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2023 | 1 |
About Davide Soldato
Davide Soldato is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 30 papers that have together received 320 indexed citations. Recurring topics across this work include Cancer Risks and Factors (5 papers), Cancer survivorship and care (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Prostate Cancer Treatment and Research (3 papers), Global Cancer Incidence and Screening (3 papers), Cancer Genomics and Diagnostics (2 papers), Coffee research and impacts (2 papers) and Ovarian function and disorders (2 papers). The work is most often cited by research in Oncology (166 citations), Cancer Research (42 citations), Pulmonary and Respiratory Medicine (77 citations), Reproductive Medicine (13 citations) and Health Informatics (2 citations). Davide Soldato has collaborated with scholars based in Italy, France and Belgium. Frequent co-authors include Antonio Di Meglio, Matteo Lambertini, Daniele Presti, Francesco Boccardo, Carlo Messina, Elisa Zanardi, Elena Castro, Carlo Cattrini, David Olmos and Orazio Caffo. Their work appears in journals such as Annals of Oncology, ESMO Open, Journal of Clinical Oncology, Clinical Breast Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.